This study was undertaken to suggest a strategy for improving the recombinant pharmaceutical industry using animal cell culture technology. The status of markets and policies of domestic and global biosimilar recombinant products and the media industry were investigated. Based on this investigation, we suggest seven ideas for improving technical development and the licensing, production, and market launch phases as a strategy for improving the recombinant pharmaceutical industry using animal cell culture technology.
서 론(Introduction)
방 법(Methods)
결 과(Results)
고 찰(Discussion)
결 론(Conclusion)
감사의 말씀(Acknowledgment)
Conflict of Interest
References